ALK-Abello A/S
OTC:AKBLF
Intrinsic Value
ALK-Abello A/S is a DK-based company operating in Pharmaceuticals industry. [ Read More ]
The intrinsic value of one AKBLF stock under the Base Case scenario is 21.3 USD. Compared to the current market price of 17.9 USD, ALK-Abello A/S is Undervalued by 16%.
Valuation Backtest
ALK-Abello A/S
Run backtest to discover the historical profit from buying and selling AKBLF stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
ALK-Abello A/S
Current Assets | 3B |
Cash & Short-Term Investments | 474m |
Receivables | 924m |
Other Current Assets | 1.6B |
Non-Current Assets | 3.8B |
PP&E | 2.2B |
Intangibles | 671m |
Other Non-Current Assets | 906m |
Current Liabilities | 1.3B |
Accounts Payable | 128m |
Other Current Liabilities | 1.2B |
Non-Current Liabilities | 965m |
Long-Term Debt | 439m |
Other Non-Current Liabilities | 526m |
Earnings Waterfall
ALK-Abello A/S
Revenue
|
4.8B
DKK
|
Cost of Revenue
|
-1.8B
DKK
|
Gross Profit
|
3B
DKK
|
Operating Expenses
|
-2.4B
DKK
|
Operating Income
|
666m
DKK
|
Other Expenses
|
-180m
DKK
|
Net Income
|
486m
DKK
|
Free Cash Flow Analysis
ALK-Abello A/S
What is Free Cash Flow?
AKBLF Profitability Score
Profitability Due Diligence
ALK-Abello A/S's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
ALK-Abello A/S's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
AKBLF Solvency Score
Solvency Due Diligence
ALK-Abello A/S's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
ALK-Abello A/S's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AKBLF Price Targets Summary
ALK-Abello A/S
According to Wall Street analysts, the average 1-year price target for AKBLF is 19.21 USD .
Shareholder Return
ALK B Price
ALK-Abello A/S
Average Annual Return | 24.63% |
Standard Deviation of Annual Returns | 45.83% |
Max Drawdown | -59% |
Market Capitalization | 27.8B DKK |
Shares Outstanding | 221 189 247 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
ALK-Abello A/S is a DK-based company operating in Pharmaceuticals industry. ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. The company is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company’s allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product offering comprises products for the management of anaphylaxis. Its allergy diagnostics product offering comprises allergen extracts for allergy testing, such as skin-prick tests. The firm operates worldwide through subsidiaries, production units and distributors in such countries as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States and China.
Officers
The intrinsic value of one AKBLF stock under the Base Case scenario is 21.3 USD.
Compared to the current market price of 17.9 USD, ALK-Abello A/S is Undervalued by 16%.